Lowe Brockenbrough & Co’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $15.7M | Sell |
31,928
-287
| -0.9% | -$156K | 0.78% | 39 |
|
|
2025
Q4 | $18.7M | Buy |
32,215
+345
| +1% | +$195K | 0.92% | 28 |
|
|
2025
Q3 | $15.5M | Buy |
31,870
+1,783
| +6% | +$830K | 0.8% | 36 |
|
|
2025
Q2 | $12.2M | Sell |
30,087
-1,055
| -3% | -$441K | 0.69% | 42 |
|
|
2025
Q1 | $15.5M | Sell |
31,142
-83
| -0.3% | -$45K | 1.02% | 23 |
|
|
2024
Q4 | $16.3M | Sell |
31,225
-754
| -2% | -$415K | 1.04% | 23 |
|
|
2024
Q3 | $19.8M | Sell |
31,979
-1,396
| -4% | -$826K | 1.26% | 18 |
|
|
2024
Q2 | $18.5M | Sell |
33,375
-190
| -0.6% | -$109K | 1.23% | 21 |
|
|
2024
Q1 | $19.5M | Buy |
33,565
+1,769
| +6% | +$993K | 1.32% | 15 |
|
|
2023
Q4 | $16.9M | Sell |
31,796
-4,148
| -12% | -$2.01M | 1.31% | 17 |
|
|
2023
Q3 | $18.2M | Sell |
35,944
-1,535
| -4% | -$818K | 1.41% | 16 |
|
|
2023
Q2 | $19.6M | Buy |
37,479
+333
| +0.9% | +$180K | 1.48% | 14 |
|
|
2023
Q1 | $21.4M | Buy |
37,146
+746
| +2% | +$420K | 1.74% | 10 |
|
|
2022
Q4 | $20.1M | Sell |
36,400
-737
| -2% | -$391K | 1.75% | 9 |
|
|
2022
Q3 | $18.8M | Sell |
37,137
-1,764
| -5% | -$987K | 1.81% | 6 |
|
|
2022
Q2 | $21.1M | Sell |
38,901
-13
| -0% | -$7.16K | 1.85% | 5 |
|
|
2022
Q1 | $23M | Sell |
38,914
-751
| -2% | -$431K | 1.7% | 8 |
|
|
2021
Q4 | $26.5M | Buy |
39,665
+1,150
| +3% | +$718K | 1.93% | 7 |
|
|
2021
Q3 | $22M | Sell |
38,515
-1,138
| -3% | -$625K | 1.71% | 8 |
|
|
2021
Q2 | $20M | Buy |
39,653
+629
| +2% | +$297K | 1.8% | 7 |
|
|
2021
Q1 | $17.8M | Buy |
39,024
+189
| +0.5% | +$90.2K | 1.73% | 8 |
|
|
2020
Q4 | $18.1M | Buy |
38,835
+683
| +2% | +$320K | 1.96% | 7 |
|
|
2020
Q3 | $16.8M | Sell |
38,152
-399
| -1% | -$165K | 2.09% | 5 |
|
|
2020
Q2 | $14M | Sell |
38,551
-348
| -0.9% | -$117K | 1.88% | 8 |
|
|
2020
Q1 | $11M | Sell |
38,899
-14,939
| -28% | -$4.71M | 1.82% | 11 |
|
|
2019
Q4 | $17.5M | Sell |
53,838
-340
| -0.6% | -$103K | 2.17% | 5 |
|
|
2019
Q3 | $15.8M | Buy |
54,178
+292
| +0.5% | +$83.6K | 2.12% | 6 |
|
|
2019
Q2 | $15.8M | Sell |
53,886
-1,140
| -2% | -$314K | 2.16% | 7 |
|
|
2019
Q1 | $15.1M | Sell |
55,026
-691
| -1% | -$172K | 2.11% | 7 |
|
|
2018
Q4 | $12.5M | Sell |
55,717
-70
| -0.1% | -$16.4K | 2.04% | 8 |
|
|
2018
Q3 | $13.6M | Sell |
55,787
-1,001
| -2% | -$230K | 1.9% | 10 |
|
|
2018
Q2 | $11.8M | Sell |
56,788
-439
| -0.8% | -$93.2K | 1.73% | 11 |
|
|
2018
Q1 | $11.8M | Sell |
57,227
-2,518
| -4% | -$529K | 1.75% | 9 |
|
|
2017
Q4 | $11.3M | Sell |
59,745
-595
| -1% | -$114K | 1.63% | 12 |
|
|
2017
Q3 | $11.4M | Sell |
60,340
-622
| -1% | -$113K | 1.75% | 11 |
|
|
2017
Q2 | $10.6M | Sell |
60,962
-3,161
| -5% | -$531K | 1.67% | 11 |
|
|
2017
Q1 | $9.85M | Sell |
64,123
-780
| -1% | -$119K | 1.57% | 14 |
|
|
2016
Q4 | $9.16M | Sell |
64,903
-6,035
| -9% | -$890K | 1.53% | 15 |
|
|
2016
Q3 | $11.3M | Sell |
70,938
-911
| -1% | -$140K | 1.95% | 7 |
|
|
2016
Q2 | $10.6M | Sell |
71,849
-660
| -0.9% | -$97.4K | 1.85% | 8 |
|
|
2016
Q1 | $10.3M | Sell |
72,509
-1,710
| -2% | -$229K | 1.77% | 11 |
|
|
2015
Q4 | $10.5M | Sell |
74,219
-978
| -1% | -$130K | 1.79% | 9 |
|
|
2015
Q3 | $9.2M | Sell |
75,197
-1,002
| -1% | -$131K | 1.61% | 11 |
|
|
2015
Q2 | $9.89M | Sell |
76,199
-780
| -1% | -$102K | 1.59% | 11 |
|
|
2015
Q1 | $10.3M | Sell |
76,979
-1,164
| -1% | -$150K | 1.63% | 11 |
|
|
2014
Q4 | $9.79M | Sell |
78,143
-2,760
| -3% | -$336K | 1.56% | 14 |
|
|
2014
Q3 | $9.85M | Sell |
80,903
-992
| -1% | -$121K | 1.57% | 11 |
|
|
2014
Q2 | $9.66M | Buy |
81,895
+106
| +0.1% | +$12.5K | 1.54% | 11 |
|
|
2014
Q1 | $9.83M | Sell |
81,789
-3,470
| -4% | -$413K | 1.64% | 10 |
|
|
2013
Q4 | $9.49M | Sell |
85,259
-4,095
| -5% | -$407K | 1.57% | 10 |
|
|
2013
Q3 | $8.23M | Sell |
89,354
-1,230
| -1% | -$111K | 1.5% | 13 |
|
|
2013
Q2 | $7.67M | Buy |
+90,584
| New | +$7.54M | 1.42% | 14 |
|
Other funds holding TMO
VCM
Lowe Brockenbrough & Co's TMO Position: Q1 2026 in Review
Lowe Brockenbrough & Co reduced its Thermo Fisher Scientific (TMO) stake by 0.89% in Q1 2026, selling an estimated $156K and leaving 31,928 shares worth $15.7M. The position accounts for 0.78% of the portfolio, ranked #39.
Lowe Brockenbrough & Co first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $26.5M in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Lowe Brockenbrough & Co held 31,928 shares of Thermo Fisher Scientific worth $15.7M as of Q1 2026.
- Lowe Brockenbrough & Co sold 287 Thermo Fisher Scientific shares in Q1 2026, an estimated $156K.
- Thermo Fisher Scientific made up 0.78% of Lowe Brockenbrough & Co's portfolio in Q1 2026, its #39 holding.
- Lowe Brockenbrough & Co first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Lowe Brockenbrough & Co's Thermo Fisher Scientific position peaked at $26.5M in Q4 2021.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Lowe Brockenbrough & Co's 13F filing for Q1 2026, filed 7 May 2026.